Benefits of Convalescent Plasma for COVID-19 Still Unclear
Despite some anecdotal evidence, scientists still don't have high-quality data showing that the treatment actually works
Study is the first to experimentally determine which byproducts from the mutation of tumors have the ability to provoke the immune system into recognizing and killing cancer cells in multiple myeloma patients